Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from StemCell Institute ( (JP:7096) ).
StemCell Institute Inc. has entered a joint venture with BIG RAINBOW INVESTMENT PTE. LTD., the family office of Sinar Mas Group, to expand its cell banking business in Southeast Asia. This strategic partnership aims to leverage StemCell’s expertise and the local networks of Sinar Mas Group to strengthen its presence and achieve sustainable growth in the region, with plans to explore related regenerative medicine services.
More about StemCell Institute
StemCell Institute Inc. operates in the biotechnology industry, specializing in cell storage services using cord blood and perinatal tissue. As a leading company in Japan with a dominant market share, it focuses on expanding its cell banking business into the Southeast Asian market.
Average Trading Volume: 38,772
Technical Sentiment Signal: Sell
Current Market Cap: Yen9.73B
For an in-depth examination of 7096 stock, go to TipRanks’ Overview page.